Connect with us

Health

Vitality Biopharma Inc (OTCMKTS:VBIO)’s Participation In Biotech Showcase Shows It’s Ready For The Race

Published

on

Vitality Biopharma Inc

Vitality Biopharma Inc (OTCMKTS:VBIO) recently took part in what is said to be the largest annual healthcare investor conferences. The company’s participation in Ninth Annual Biotech Showcase 2017 Conference will assist it in establishing itself as a ferocious and serious market player in the cannabinoids market.  Here is how.

Approval of cannaboside pharmaceutical research

As 2016 closed in, the company announced in December 2016 that the State of California Research Advisory Panel and U.S. Drug Enforcement Agency (DEA) gave their nod to scale up activities for developing novel cannabinoid pharmaceutical prodrugs at its facilities. This is an important development and announcement from the company; especially in the times when the new U.S. elected President is about to take up the throne. The heat surrounding the cannabis industry has risen and so, for any company of this industry, seeking new opportunities is indeed profitable.

Vitality is focussed on development of its THC and Hemp prodrugs through research and more greenlights from the regulators.

Ninth Annual Biotech Showcase 2017 Conference important for pharmaceutical industry

This is one conference which gives a lucrative prospect to the companies to partner with new investors. This investor and partnering conference is not just devoted to public companies, but also the private companies across biotechnology and life sciences industries. So, there is a possibility of meeting new pharmaceutical executives, along with investors and convincing them of the bright future of the company.

Vitality Biopharma’s participation in this conference means that it has indicated or shown that it is active in the industry and ready to take on the fight in the industry.  Through this conference, it can also highlight the regulators’ approval to enhance its production of products, in the times to come.

Vitality Biopharma is therefore, in the direction of competitive era of cannabis industry. The times ahead, at least from here, seem to be bright and positive for the marijuana industry.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.